CME and CFTC Clash Over On-Chain Perpetual Futures

The dispute between the CME, the largest derivatives exchange operator in the US, and its regulator, the Commodity Futures Trading Commission (CFTC), centers on the agency's decision to allow the listing of blockchain-based perpetual futures products. The CME has sued the CFTC, challenging its decision to permit the listing of these products, which are decentralized derivative contracts that enable users to speculate on the price of an asset with leverage and no expiration date. The CME argues that the CFTC is mislabeling these products and therefore misapplying the law, as futures require an end date, whereas perpetual futures do not. The lawsuit claims that the CFTC's sudden embrace of perpetual futures did not consider the ramifications and will harm the CME's long-dated futures products. The tension between the two entities escalated around the start of the Iran conflict, which saw a surge in interest in perpetual contracts on oil prices traded on offshore decentralized finance (DeFi) exchanges. The CFTC's reforming agenda has been met with frustration from some quarters, with critics arguing that the regulator is not considering the full implications of its actions. The CME's attempt to fast-track 24/7 trading for crude oil futures was blocked by the CFTC, further exacerbating the dispute. The CFTC's chairman, Mike Selig, has declined to comment on the matter, but the CME's chairman, Terry Duffy, has been vocal in his criticism of the regulator's approach, arguing that the definition of a swap is clear and that the CFTC is not following protocol. The dispute is likely to have significant implications for the US approach to the rapidly growing arena of perpetual futures, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CME's stance on crypto perpetual futures has been viewed by some as typical of the way large incumbents handle innovation that might threaten their dominance. The future of CFTC-driven perps remains uncertain as the CME readies its case, which includes claims that the agency rubber-stamped the Kalshi application without issuing a regulation or seeking public comment. The regulatory and tax regimes for swaps and futures are different, and the distinction matters in this legal dispute.